Business, energy, technology, markets and global industry news from Business News Today

National Institute for Health and Care Excellence

PharmaDeviceNews National Institute for Health and Care Excellence
Dunbar Pharma targets UK compounding market with EU GMP dronabinol API
Pharma & Biotech

UK already had dronabinol APIs. What makes Dunbar Pharma’s plant-derived entry different?

Dunbar Pharma brings plant-derived dronabinol API to the UK through IPS Pharma, opening a new pharmaceutical cannabinoid supply route.

Read More
Representative image: A cardiologist reviews heart imaging as Cytokinetics’ $CYTK aficamten gains UK approval and NICE backing for approximately 6,600 adults with symptomatic obstructive hypertrophic cardiomyopathy.
Pharma & Biotech

Aficamten wins UK approval and NICE backing for 6,600 adults with obstructive HCM

Aficamten gains UK authorisation and NICE backing for symptomatic obstructive HCM after Phase 3 improvements in exercise capacity.

Read More
Representative image of an oncology consultation as Imfinzi moves toward becoming the first NHS immunotherapy option for eligible stomach cancer patients in England, marking a potential shift in gastric cancer treatment pathways.
Pharma & Biotech

AstraZeneca’s Imfinzi becomes first NHS immunotherapy for operable stomach cancer

Stomach cancer care gains immunotherapy, but NHS adoption now depends on surgery timing, toxicity management and recurrence data.

Read More
Representative image: A clinician reviews pelvic imaging and biomarker data in a women’s health diagnostics setting, reflecting how non-invasive endometriosis tests using saliva, blood and molecular imaging could help shorten years-long diagnosis delays.
Features & Analysis

Is endometriosis diagnosis finally moving beyond surgery after years of missed symptoms?

Endometriosis testing is escaping the surgery-first era. Saliva, blood and imaging tools now face the harder test: clinical utility.

Read More